156
Views
1
CrossRef citations to date
0
Altmetric
Review

The role of serial right heart catheterization in risk stratification and management of pulmonary arterial hypertension

, , , , ORCID Icon, , & show all
Pages 543-547 | Received 09 Mar 2022, Accepted 16 Jun 2022, Published online: 22 Jun 2022

References

  • Galie N, Humbert M, Vachiery JL, et al. ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European society of cardiology (ESC) and the European respiratory society (ERS): endorsed by: association for European paediatric and congenital cardiology (AEPC), international society for heart and lung transplantation (ISHLT). Eur Heart J. 2015;37(1):67–119. 2016.
  • Benza RL, Gomberg-Maitland M, Miller DP, et al., The REVEAL registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension. Chest. 141(2): 354–362. 2012.
  • Benza RL, Miller DP, Gomberg-Maitland M, et al. Predicting survival in pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL). Circulation. 2010;122(2):164–172.
  • Humbert M, Sitbon O, Yaici A, et al., Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J. 36(3): 549–555. 2010.
  • Humbert M, Sitbon O, Chaouat A, et al., Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation. 122(2): 156–163. 2010.
  • Lee WT, Ling Y, Sheares KK, et al. Predicting survival in pulmonary arterial hypertension in the UK. Eur Respir J. 2012;40(3):604–611.
  • Kylhammar D, Kjellstrom B, Hjalmarsson C, et al., A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension. Eur Heart J. 39(47): 4175–4181. 2018.
  • Radegran G, Kjellstrom B, Ekmehag B, et al. Characteristics and survival of adult Swedish PAH and CTEPH patients 2000-2014. Scand Cardiovasc J. 2016;50(4):243–250.
  • Hoeper MM, Kramer T, Pan Z, et al. Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model. Eur Respir J. 2017;50(2).
  • Galie N, Channick RN, Frantz RP, et al. Risk stratification and medical therapy of pulmonary arterial hypertension. Eur Respir J. 2019;53(1).
  • Nickel N, Golpon H, Greer M, et al. The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension. Eur Respir J. 2012;39(3):589–596.
  • Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Kardiol Pol. 2015;73(12):1127–1206.
  • Hoeper MM, Lee SH, Voswinckel R, et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol. 2006;48(12):2546–2552.
  • Zuckerman WA, Turner ME, Kerstein J, et al. Safety of cardiac catheterization at a center specializing in the care of patients with pulmonary arterial hypertension. Pulm Circ. 2013;3(4):831–839.
  • Warwick G, Thomas PS, Yates DH. Biomarkers in pulmonary hypertension. Eur Respir J. 2008;32(2):503–512.
  • Benza RL, Gomberg-Maitland M, Elliott CG, et al. Predicting survival in patients with pulmonary arterial hypertension: the REVEAL risk score calculator 2.0 and comparison with ESC/ERS-based risk assessment strategies. Chest. 2019;156(2):323–337.
  • Goerne H, Batra K, Rajiah P. Imaging of pulmonary hypertension: an update. Cardiovascular Diagnosis and Therapy. 2018;8(3):279–296.
  • Benza RL, Kanwar MK, Raina A, et al. Development and validation of an abridged version of the REVEAL 2.0 risk score calculator, REVEAL lite 2, for use in patients with pulmonary arterial hypertension. Chest. 2021;159(1):337–346.
  • Hoeper MM, Pittrow D, Opitz C, et al. Risk assessment in pulmonary arterial hypertension. Eur Respir J. 2018;51(3).
  • Ullah W, Minalyan A, Saleem S, et al. Comparative accuracy of non-invasive imaging versus right heart catheterization for the diagnosis of pulmonary hypertension: a systematic review and meta-analysis. Int J Cardiol Heart Vasc. 2020;29:100568.
  • Rosenkranz S, Preston IR. Right heart catheterisation: best practice and pitfalls in pulmonary hypertension. Eur Respir Rev. 2015;24(138):642–652.
  • Humbert M, Weatherald J. Right heart catheterisation is still a fundamental part of the follow-up assessment of pulmonary arterial hypertension. Eur Respir J. 2018 Jul;52(1):1800738.
  • Galiè N, McLaughlin VV, Rubin LJ, et al. An overview of the 6th world symposium on pulmonary hypertension. Eur Respir J. 2019;53(1):1802148.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.